QUMAS, a provider of Compliance Solutions to highly regulated companies, announced the launch of its Enterprise Compliance Solution for Microsoft SharePoint 2010 at the 46th Annual Drug Information Association (DIA) Conference. The solution addresses all aspects of compliance content and process management, from Clinical through Regulatory, and on to Sales & Marketing, IT and Legal.
QUMAS' domain knowledge will now be available on a SharePoint 2010 platform.
"We have been approached by a number of firms that intend to make SharePoint 2010 a cornerstone of their technology infrastructure," said Kevin O'Leary, CEO QUMAS. " We recognize the game changing impact that SharePoint is having on the technology landscape. This is the single most exciting initiative we have undertaken in our 16 years of business and we are delighted to be working with Microsoft to deliver a compliance solution built entirely on the SharePoint 2010 platform."
The QUMAS Compliance Solution adds key solution-specific functionality that leverages and extends the underlying SharePoint platform to support industry demands in a number of key areas. These will include:
-Manufacturing Controlled Documents
-CAPA's and Deviations
-Clinical Trial Management
-Regulatory Documentation
-SOP Management (Policies and Procedures)
-Customer Complaints
-Change Control
-Policy Training and Certification
-R&D Document Control
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
2 Commerce Drive
Cranbury, NJ 08512